
Niloofar Rahmani
Examiner (ID: 12602, Phone: (571)272-4329 , Office: P/1625 )
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1625, 1691, 1621 |
| Total Applications | 2303 |
| Issued Applications | 1739 |
| Pending Applications | 128 |
| Abandoned Applications | 466 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4746215
[patent_doc_number] => 20080090817
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-17
[patent_title] => 'Bridged N-Cyclic Sulfonamido Inhibitors of Gamma Secretase'
[patent_app_type] => utility
[patent_app_number] => 11/951097
[patent_app_country] => US
[patent_app_date] => 2007-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52549
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0090/20080090817.pdf
[firstpage_image] =>[orig_patent_app_number] => 11951097
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/951097 | Bridged N-cyclic sulfonamido inhibitors of gamma secretase | Dec 4, 2007 | Issued |
Array
(
[id] => 6007971
[patent_doc_number] => 20110060002
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-10
[patent_title] => 'CONGLOMERATES OF TENATOPRAZOLE POTASSIUM SALTS'
[patent_app_type] => utility
[patent_app_number] => 12/448055
[patent_app_country] => US
[patent_app_date] => 2007-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6644
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0060/20110060002.pdf
[firstpage_image] =>[orig_patent_app_number] => 12448055
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/448055 | Conglomerates of tenatoprazole potassium salts | Dec 2, 2007 | Issued |
Array
(
[id] => 6257763
[patent_doc_number] => 20100029710
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-04
[patent_title] => 'COMPOUNDS HAVING BOTH ANGIOTENSIN II RECEPTOR ANTAGONISM AND PPARy ACTIVATING ACTIVITIES'
[patent_app_type] => utility
[patent_app_number] => 12/518472
[patent_app_country] => US
[patent_app_date] => 2007-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 53985
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20100029710.pdf
[firstpage_image] =>[orig_patent_app_number] => 12518472
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/518472 | COMPOUNDS HAVING BOTH ANGIOTENSIN II RECEPTOR ANTAGONISM AND PPARy ACTIVATING ACTIVITIES | Dec 2, 2007 | Abandoned |
Array
(
[id] => 8784750
[patent_doc_number] => 08431593
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-04-30
[patent_title] => 'Heteroaryl amide derivatives'
[patent_app_type] => utility
[patent_app_number] => 12/516480
[patent_app_country] => US
[patent_app_date] => 2007-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 57803
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12516480
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/516480 | Heteroaryl amide derivatives | Nov 26, 2007 | Issued |
Array
(
[id] => 6455707
[patent_doc_number] => 20100105723
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-29
[patent_title] => '5-PHENYL-6-PYRIDIN-4-YL-1,3-DIHYDRO-2H-IMIDAZO[4,5-b]PYRIDIN-2-ONE DERIVATIVES USEFUL AS A2B ADENOSINE RECEPTOR ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 12/521133
[patent_app_country] => US
[patent_app_date] => 2007-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5747
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20100105723.pdf
[firstpage_image] =>[orig_patent_app_number] => 12521133
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/521133 | 5-PHENYL-6-PYRIDIN-4-YL-1,3-DIHYDRO-2H-IMIDAZO[4,5-b]PYRIDIN-2-ONE DERIVATIVES USEFUL AS A2B ADENOSINE RECEPTOR ANTAGONISTS | Nov 22, 2007 | Abandoned |
Array
(
[id] => 5272270
[patent_doc_number] => 20090076046
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'Compounds modulating c-fms and/or c-kit activity and uses therefor'
[patent_app_type] => utility
[patent_app_number] => 11/986667
[patent_app_country] => US
[patent_app_date] => 2007-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 144145
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20090076046.pdf
[firstpage_image] =>[orig_patent_app_number] => 11986667
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/986667 | Compounds modulating c-fms and/or c-kit activity and uses therefor | Nov 20, 2007 | Issued |
Array
(
[id] => 123569
[patent_doc_number] => 07705152
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-04-27
[patent_title] => 'Alcohol oxidation catalyst and its preparation process'
[patent_app_type] => utility
[patent_app_number] => 11/943836
[patent_app_country] => US
[patent_app_date] => 2007-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 7071
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/705/07705152.pdf
[firstpage_image] =>[orig_patent_app_number] => 11943836
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/943836 | Alcohol oxidation catalyst and its preparation process | Nov 20, 2007 | Issued |
Array
(
[id] => 53319
[patent_doc_number] => 07772239
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-08-10
[patent_title] => 'Benzoimidazolone-carboxamide compounds as 5-HT4 receptor agonists'
[patent_app_type] => utility
[patent_app_number] => 11/986212
[patent_app_country] => US
[patent_app_date] => 2007-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 23184
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/772/07772239.pdf
[firstpage_image] =>[orig_patent_app_number] => 11986212
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/986212 | Benzoimidazolone-carboxamide compounds as 5-HT4 receptor agonists | Nov 19, 2007 | Issued |
Array
(
[id] => 6258545
[patent_doc_number] => 20100029944
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-04
[patent_title] => 'Process for the Synthesis of Solifenacin'
[patent_app_type] => utility
[patent_app_number] => 12/515689
[patent_app_country] => US
[patent_app_date] => 2007-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4497
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20100029944.pdf
[firstpage_image] =>[orig_patent_app_number] => 12515689
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/515689 | Process for the Synthesis of Solifenacin | Nov 19, 2007 | Abandoned |
Array
(
[id] => 247124
[patent_doc_number] => 07585876
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-09-08
[patent_title] => 'Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands'
[patent_app_type] => utility
[patent_app_number] => 11/941479
[patent_app_country] => US
[patent_app_date] => 2007-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14866
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/585/07585876.pdf
[firstpage_image] =>[orig_patent_app_number] => 11941479
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/941479 | Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands | Nov 15, 2007 | Issued |
Array
(
[id] => 4753189
[patent_doc_number] => 20080161264
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-03
[patent_title] => 'TRIAZOLYL TROPANE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 11/941925
[patent_app_country] => US
[patent_app_date] => 2007-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11694
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0161/20080161264.pdf
[firstpage_image] =>[orig_patent_app_number] => 11941925
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/941925 | Triazolyl tropane derivatives | Nov 15, 2007 | Issued |
Array
(
[id] => 102746
[patent_doc_number] => 07723355
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-05-25
[patent_title] => '7,8-dihydro-1,6-naphthyridin-5(6H)-ones and related bicyclic compounds as inhibitors of dipeptidyl peptidase IV and methods'
[patent_app_type] => utility
[patent_app_number] => 11/941181
[patent_app_country] => US
[patent_app_date] => 2007-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19693
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/723/07723355.pdf
[firstpage_image] =>[orig_patent_app_number] => 11941181
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/941181 | 7,8-dihydro-1,6-naphthyridin-5(6H)-ones and related bicyclic compounds as inhibitors of dipeptidyl peptidase IV and methods | Nov 15, 2007 | Issued |
Array
(
[id] => 4765682
[patent_doc_number] => 20080176894
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-24
[patent_title] => 'Novel aminopyridine-derivatives'
[patent_app_type] => utility
[patent_app_number] => 11/984364
[patent_app_country] => US
[patent_app_date] => 2007-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23200
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20080176894.pdf
[firstpage_image] =>[orig_patent_app_number] => 11984364
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/984364 | Aminopyridine-derivatives | Nov 15, 2007 | Issued |
Array
(
[id] => 159433
[patent_doc_number] => 07674795
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-03-09
[patent_title] => 'Fluorene derivatives, composition containing said derivatives and the use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/939735
[patent_app_country] => US
[patent_app_date] => 2007-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 102146
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/674/07674795.pdf
[firstpage_image] =>[orig_patent_app_number] => 11939735
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/939735 | Fluorene derivatives, composition containing said derivatives and the use thereof | Nov 13, 2007 | Issued |
Array
(
[id] => 4887905
[patent_doc_number] => 20080262237
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-23
[patent_title] => 'BLACK PIGMENT, BLACK PIGMENT DISPERSION AND BLACK RESIN COMPOSITION COMPRISING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 11/938990
[patent_app_country] => US
[patent_app_date] => 2007-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8557
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0262/20080262237.pdf
[firstpage_image] =>[orig_patent_app_number] => 11938990
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/938990 | Black pigment, black pigment dispersion and black resin composition comprising the same | Nov 12, 2007 | Issued |
Array
(
[id] => 8257714
[patent_doc_number] => 08207193
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-06-26
[patent_title] => 'Quiniclidine derivatives of (hetero) arylcycloheptanecarboxylic acid as muscarinic receptor antagonists'
[patent_app_type] => utility
[patent_app_number] => 12/514509
[patent_app_country] => US
[patent_app_date] => 2007-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25041
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12514509
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/514509 | Quiniclidine derivatives of (hetero) arylcycloheptanecarboxylic acid as muscarinic receptor antagonists | Nov 12, 2007 | Issued |
Array
(
[id] => 6257371
[patent_doc_number] => 20100029643
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-04
[patent_title] => 'HETEROCYCLYC SULFONAMIDES HAVING EDG-1 ANTAGONISTIC ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 12/514247
[patent_app_country] => US
[patent_app_date] => 2007-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53507
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20100029643.pdf
[firstpage_image] =>[orig_patent_app_number] => 12514247
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/514247 | HETEROCYCLYC SULFONAMIDES HAVING EDG-1 ANTAGONISTIC ACTIVITY | Nov 7, 2007 | Abandoned |
Array
(
[id] => 8082087
[patent_doc_number] => 08148361
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-04-03
[patent_title] => 'Kinase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/513928
[patent_app_country] => US
[patent_app_date] => 2007-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12948
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/148/08148361.pdf
[firstpage_image] =>[orig_patent_app_number] => 12513928
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/513928 | Kinase inhibitors | Nov 6, 2007 | Issued |
Array
(
[id] => 4873733
[patent_doc_number] => 20080200467
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-21
[patent_title] => 'SOLUBLE EPOXIDE HYDROLASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 11/934698
[patent_app_country] => US
[patent_app_date] => 2007-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36023
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0200/20080200467.pdf
[firstpage_image] =>[orig_patent_app_number] => 11934698
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/934698 | SOLUBLE EPOXIDE HYDROLASE INHIBITORS | Nov 1, 2007 | Abandoned |
Array
(
[id] => 4965830
[patent_doc_number] => 20080108650
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-08
[patent_title] => 'Phosphodiesterase 10A inhibitor'
[patent_app_type] => utility
[patent_app_number] => 11/980526
[patent_app_country] => US
[patent_app_date] => 2007-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2084
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0108/20080108650.pdf
[firstpage_image] =>[orig_patent_app_number] => 11980526
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/980526 | Phosphodiesterase 10A inhibitor | Oct 30, 2007 | Issued |